CDKN2A and neoplasm: Studies have shown (94) that activation of the Notch signaling pathway can inhibit the expression of INK4a/ARF gene, promote the degradation of p53 by MDM2, down-regulate the oncogenic effect of p53 and inhibit the apoptosis of tumor cells.